Treatment Patterns and Outcomes in Patients with Relapsed ...

Treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma receiving ≥3 lines of therapy: a real-world evaluation in the United ...

Treatment patterns and outcomes of patients with relapsed or ...

Patients with relapsed or refractory follicular lymphoma receive heterogeneous treatments in the third-line setting or later.

Treatment Patterns and Outcomes of Patients with Relapsed ...

Our purpose was to describe treatment patterns, survival outcomes and duration of response in patients with non-transformed multiply R/R FL receiving three or ...

Treatment Patterns and Outcomes in Patients with Relapsed or ...

Introduction: First-line (1L) therapy for diffuse large B-cell lymphoma (DLBCL) can cure ~60% of patients (pts), but ~10-15% do not respond ...

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ...

Treatment patterns observed were consistent with previous RW studies, with significant use of BOR- and LEN-based regimens noted in 1L and 2L, whereas newer ...

Current real-world treatment patterns and outcomes in patients with ...

Survival outcomes based on these patterns agreed with trial estimates of early-line standard of care therapies but were lower than those reported for newly ...

Treatment patterns and outcomes of patients with relapsed or ...

The main endpoints of interest were overall response rate, progression-free survival, and overall survival. Outcomes were also evaluated in subsets of clinical ...

results from the international SCHOLAR-5 study | Haematologica

Treatment patterns and clinical outcomes observed in the international SCHOLAR-5 study – a large, contemporary cohort of later line r/r FL ...

Recent real-world treatment patterns and outcomes in US patients ...

In patients with relapsed/refractory multiple myeloma (RRMM) previously receiving 1–3 therapy lines, newer agents demonstrated improved outcomes versus older ...

Treatment patterns and outcomes of patients with relapsed or ...

Interpretation: Patients with relapsed or refractory follicular lymphoma receive heterogeneous treatments in the third-line setting or later. We observed high ...

Treatment patterns and outcomes of patients with relapsed or ...

Fingerprint. Dive into the research topics of 'Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or ...

Evolving treatment patterns and improved outcomes in relapsed ...

There is no consensus on preferred 2 L therapy at the time of relapse, with treatment selection impacted by patient factors, frontline therapy, ...

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ...

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WITH AT LEAST TWO PRIOR THERAPIES IN BRAZIL. Visits. 480.

Treatment Patterns and Outcomes Among Patients with Relapsed ...

... patients with relapsed/refractory (R/R) FL. ... The objective of this study was to assess real-world treatment patterns and outcomes among ...

REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN ...

REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WITH AT LEAST ONE PRIOR THERAPY IN TURKEY.

Refractory Multiple Myeloma with At Least Two Prior Therapies in ...

Real-World Treatment Patterns and Outcomes in Patients with Relapsed/ ... treatment patterns, and clinical outcomes among RRMM patients who.

Treatment Patterns and Disease Outcomes of Patients With ...

Progressive or relapsed HL is responsive to salvage RT, with a relatively low LF rate following moderate RT doses. Overall survival is excellent despite ...

Treatment patterns and clinical outcomes among patients with ...

Half of the sample was stage III/IV at initial cHL diagnosis, and approximately 79.4% of cHL patients relapsed after their initial cHL diagnosis, compared with ...

Treatment Patterns and Survival Outcomes in Patients With ...

Although the OS rate following first-line therapy was high in this FL cohort, significant differences were observed between early and non-early ...

Treatment patterns and outcomes according to cytogenetic risk ...

In clinical trials, venetoclax has shown encouraging efficacy in patients with relapsed/refractory MM and t(11;14) [23, 24]. Here, we examined ...